SNHG16 was regarded as an oncogene and associated with neuroblastoma, bladder cancer, colorectal cancer, esophageal squamous cell carcinoma, and hepatocellular carcinoma [52–54]. Here, SNHG16 is linked to urinary bladder cancer.